O4 - Optimizing urethritis treatment – M. genitalium and pathogens of idiopathic urethritis

Moderator(s)

• TB

  Teresa Batteiger, MD MS (she/her/hers)

  Assistant Professor of Medicine
  Indiana University School of Medicine
  Indianapolis, Indiana, United States
• JJ

  Jørgen Jensen

  Statens Serum Institut, United States

Presentations:

• 14:30 – 14:45 CST

  Exploring current etiologies of urethritis: associations of urethral microorganisms and urethritis among men attending 6 STD clinics in the US, 2017-2018
  

  Primary Presenter: Emily Learner, PhD MPH – Division of STD Prevention, Centers for Disease Control and Prevention
• 14:45 – 15:00 CST

  gyrA mutations in Mycoplasma genitalium contribute to moxifloxacin failure – a new target for resistance-guided therapy
  

  Primary Presenter: Gerald Murray, PhD – University of Melbourne
• 15:00 – 15:15 CST

  MgSeq: Enabling M. genitalium identification and antimicrobial resistance detection in genital and extra-genital samples from female sex workers in Ecuador using multiplex PCR and nanopore sequencing
  

  Primary Presenter: Claire Broad (she/her/hers) – St George's, University of London
• 15:15 – 15:30 CST

  Mycoplasma genitalium Surveillance Data from 2020-2022: Results from the Mycoplasma genitalium in the US (MyGeniUS) Project
  

  Primary Presenter: Lisa E. Manhart, MPH, PhD – University of Washington
• 15:30 – 15:45 CST

  Efficacy of minocycline for the treatment of Mycoplasma genitalium
  

  Primary Presenter: Lenka A. Vodstrcil, PhD (she/her/hers) – Monash University and Melbourne Sexual Health Centre
• 15:45 – 16:00 CST

  Idiopathic nongonococcal urethritis may be due to emerging and spontaneously cleared pathogens
  

  Primary Presenter: David E. Nelson, PhD – Indiana University Schol of Medicine